Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-16-139406

Options or other derivatives

  • Director acquired 217,222 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Knowles Jonathan Kenneth Charles Director 2016-08-11 Grant or award · Option to purchase Ordinary Shares +217,222 217,222 D: show line 1 in the form
Loading xslF345X03/a4.xml…